CannIntelligence, Author at CannIntelligence

CBD and hemp regulation: confusion in the US

Written by CannIntelligence || 23rd October 2020 || News analysis |

Regulation of CBD at the federal level remains confusingly divided between multiple agencies. Three main bodies have overall control of most aspects of hemp and CBD consumer product regulation ...

CBD and hemp regulation: the US DEA and its authority

Written by CannIntelligence || 23rd October 2020 || News analysis |

The passage of the 2018 Farm Bill removed hemp and compounds derived from hemp (including CBD) from the CSA. Therefore, the DEA should have very little involvement in enforcing laws and regulations on hemp and CBD ...

CBD and hemp regulation: the US FDA and its authority

Written by CannIntelligence || 23rd October 2020 || News analysis |

The US Food and Drug Administration (FDA) is a critical agency in the regulatory scheme of CBD products. The 2018 Farm Bill, which legalised hemp and CBD derived from it, granted the FDA the authority to regulate hemp...

CBD and hemp regulation: the USDA and its authority

Written by CannIntelligence || 23rd October 2020 || News analysis |

Among the most important obligations delegated to it in the Farm Bill, the USDA is responsible for rule making regarding production and testing of hemp and approving state and tribal plans for hemp production ...

What impact could a decision in the recent Dusseldorf lawsuit have on the German CBD sector?

Written by CannIntelligence || 23rd October 2020 || Blogs |

The company of the president of the European Industrial Hemp Association (EIHA) has challenged a ban on the sale of all foods containing...

Nestlé enters European CBD market with soft gel capsules

Written by CannIntelligence || 23rd October 2020 || News analysis |

Nestlé has taken a baby step into the European cannabidiol market just a year after creating its own CBD line in the US and will now distribute soft gel CBD capsules in the UK through the Pure Encapsulations...

Ministerial decree causes further confusion for the Italian market

Written by CannIntelligence || 22nd October 2020 || News analysis |

A ministerial decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law is meant to clear the way for the introduction of Epidyolex into the market, not to prevent consumer wellness products being sold...

Podcast: global CBD markets and their commonalities and differences

Written by CannIntelligence || 22nd October 2020 || Podcasts , Resources |

Our host for today’s podcast is Jon Bruford, a copy editor at CBD-Intel, who will be joined by CBD-Intel market analyst Maria Alejandra Estanga, who analyses the CBD market for European and American countries. In CBD-Intel’s new podcast,...

Lobbyists hard at work for regulatory change as US elections approach

Written by CannIntelligence || 19th October 2020 || News analysis |

With US elections on 3rd November fast approaching, lobbyists for CBD, cannabis and hemp are eager to get their message across to candidates on both sides of the political divide ...

CBD-Intel regulatory news in brief, 10th-16th October

Written by CannIntelligence || 19th October 2020 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from the EU, Belgium, France, Germany, Italy Switzerland, the UK, Canada, Mexico, the US, Argentina, Australia, Israel, New Zealand, Nigeria, Rwanda, South Africa and...

What impact will the US elections have on CBD and cannabis?

Written by CannIntelligence || 16th October 2020 || Blogs |

It's important to remember that all aspects of cannabis and CBD – even federal decriminalisation or legalisation...

Red yeast rice and stem cells could point the way ahead for FDA regulation of CBD

Written by CannIntelligence || 16th October 2020 || News analysis |

The apparently unrelated fields of red yeast rice and stem cell research could provide clues as to how the US Food and Drug Administration (FDA) might deal with market regulation of CBD ...

Regulatory report: Australia, October 2020

Written by CannIntelligence || 15th October 2020 || Regulatory reports |

CBD is listed on the Controlled Drug Register in Australia, which means it cannot be sold as a consumer product. This report offers an overview of the current regulatory framework in the country for CBD ...

CBD ads spring up at Serie A football grounds as Italy takes to home delivery

Written by CannIntelligence || 13th October 2020 || News analysis |

Matches in Serie A, the top football league in Italy, are for the first time featuring advertisements for a CBD company as the home delivery market continues to grow rapidly in the country ...

CBD-Intel regulatory news in brief, 3rd-9th October

Written by CannIntelligence || 9th October 2020 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from the EU, Austria, France Germany, Italy, the Netherlands, Slovakia, Romania, Spain, the UK, the US, Australia, Colombia, Israel, Lebanon, New Zealand, Russia and Ukraine ...

Costa Rica looks set to legalise hemp and medical cannabis production

Written by CannIntelligence || 9th October 2020 || News analysis |

A Costa Rican bill legalising the production of hemp and medical cannabis looks likely to pass due to broad support from the ruling coalition and president ...

Do companies need toxicological study data included in UK Food Standards Agency (FSA) novel food applications for them to be validated?

Written by CannIntelligence || 9th October 2020 || Blogs |

There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data...

Canada or the US: which makes the better home for your CBD or cannabis business?

Written by CannIntelligence || 8th October 2020 || News analysis |

Should CBD or cannabis companies invest in the US or Canada? There are pros and cons to each, and the same answer may not apply to everyone – or remain the same forever ...

German city’s ban on foods containing natural CBD extracts faces legal test

Written by CannIntelligence || 7th October 2020 || News analysis |

A decision by the German city of Düsseldorf to prohibit the sale of all foods containing CBD, including in natural extract form, faces a legal challenge from local hemp wholesaler Hempro International ...

A mixed blessing as US states get extra time to comply with the 2018 Farm Bill

Written by CannIntelligence || 5th October 2020 || News analysis |

The US Congress has extended by 11 months the deadline for states to get into compliance with the 2018 Farm Bill ...

CBD-Intel regulatory news in brief, 26th September-2nd October

Written by CannIntelligence || 2nd October 2020 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Austria, Belgium, Germany, France, Italy, Switzerland, UK, the US, Mexico, Australia, Colombia, Costa Rica, Uruguay and...

New regulatory measures for industrial hemp introduced in Zimbabwe

Written by CannIntelligence || 2nd October 2020 || News analysis |

The Zimbabwean agriculture minister has officially published a new statutory instrument to regulate the production, procurement, distribution, possession, sale, provision and transportation of industrial hemp ...

Is increased uncertainty in established markets driving interest in secondary markets such as Asia?

Written by CannIntelligence || 2nd October 2020 || Blogs |

There has been increased interest in secondary markets that has resulted in some positive...

Agriculture ministry decree may allow extraction from hemp flowers in Italy

Written by CannIntelligence || 1st October 2020 || News analysis |

The Italian Ministry of Agriculture has issued a ministerial decree listing hemp flowers in the catalogue of officinal plants, which forms part of the country’s medicinal and aromatic plants legislation ...

Topicals status across top CBD markets

Written by CannIntelligence || 1st October 2020 || Presentations , Resources |

Maria Alejandra Estanga, our market analysts, presented the current status of the topicals market across the most important CBD markets during the Virtual Cannacosmo Health + Beauty Expo on 29st...

Folium branches out with stalks to break into Japanese and Korean markets

Written by CannIntelligence || 29th September 2020 || News analysis |

US-based CBD producer Folium Biosciences is looking to tap Asian markets by creating a dedicated stalk extraction line which it believes will meet the strict regulatory requirements of Japan and South Korea ...

Hopes growing in Brazil for further legalisation of medical cannabis

Written by CannIntelligence || 28th September 2020 || News analysis |

A proposal to be voted on by Brazilian legislators in the coming weeks could legalise the growing of hemp for industrial purposes and cannabis for medical use ...

CBD-Intel regulatory news in brief, 19th-25th September

Written by CannIntelligence || 25th September 2020 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Spain, the UK, the US, Hong Kong, South Africa and...

What impact does the delay in voting on the MORE Act have on the CBD industry?

Written by CannIntelligence || 25th September 2020 || Blogs |

The Marijuana Opportunity Reinvestment and Expungement (MORE) Act was, of course, always more about cannabis than hemp-derived CBD specifically. And, as previously stated, its chances of passing were slim to...

Ale and hearty – a new CBD food and drinks trade springs up in Hong Kong

Written by CannIntelligence || 23rd September 2020 || News analysis |

2020 seems an unlikely year for the emergence of any new industry, yet this is exactly what has happened in Hong Kong, where there are now locally produced CBD food and drink products ...

Why do bills related to cannabinoids keep getting pushed through the US Congress?

Written by CannIntelligence || 21st September 2020 || Blogs |

There does not seem to be much point in continuing to try to force through bills – particularly given that the Republican-controlled senate and presidency opposes any measures and the limited timeframe before the end of the legislative session....

CBD-Intel regulatory news in brief, 12th-18th September

Written by CannIntelligence || 18th September 2020 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from France, Italy, Poland, Sweden, the US, the British Virgin Islands, Argentina, Australia, Ecuador, Israel, the Philippines and Russia ...

cbdMD campaign steps carefully to find the right route to TV ad acceptance

Written by CannIntelligence || 18th September 2020 || News analysis |

A TV advertising campaign for US company cbdMD demonstrates how attitudes towards CBD products are slowly changing in advertising circles – but also how much work remains to be done ...

Regulatory report: Japan, September 2020

Written by CannIntelligence || 17th September 2020 || Regulatory reports |

This regulatory report covers all aspects of the regulatory regime for hemp and CBD in Japan, including medical cannabis and import/export laws ...

British spirit-makers looking to make CBD the gin genie in the bottle

Written by CannIntelligence || 16th September 2020 || News analysis |

Britain’s newfound enthusiasm for CBD products has joined with the passion for alcohol, with some companies are aiming to capitalise on the trend for “drinking less but drinking better” by launching CBD spirits, especially gin ...

Opposing politicians attack European Commission view on ‘narcotic’ CBD

Written by CannIntelligence || 15th September 2020 || News analysis |

MEPs with very different political outlooks have attacked the European Commission’s initial opinion that CBD could be classed under United Nations conventions as a narcotic ...

Researchers suggest CBD could work with terpenes in COVID-19 treatment

Written by CannIntelligence || 14th September 2020 || News analysis |

Studies looking at the potential for CBD to treat or alleviate COVID-19 symptoms continue to progress – with one study hinting at promising results combining CBD with other terpene products ...

CBD-Intel regulatory news in brief, 5th-11th September

Written by CannIntelligence || 11th September 2020 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Czech Republic, France, Germany, Ireland, Lithuania, Malta, Netherlands, Slovakia, Ukraine, the UK, the US, Colombia, Israel and Russia ...

‘We want MORE’ – US Democrats prepare for House vote on cannabis reform bill

Written by CannIntelligence || 11th September 2020 || News analysis |

The US House of Representatives is expected to hold a historic vote this month on a comprehensive cannabis reform bill that supporters embrace for not only decriminalising marijuana but correcting injustices ...

Refined oil regional wholesale pricing

Written by CannIntelligence || 8th September 2020 || News analysis |

Regional wholesale pricing analysis for refined oil as well as our impartial insights to help you effectively make data-backed...

CBD industry steps up with funding for ValidCare’s vital liver function study

Written by CannIntelligence || 7th September 2020 || News analysis |

More than a dozen CBD businesses have given their backing to an investigation of the impact of CBD on liver toxicity levels in order to provide regulatory authorities in the US with reliable new data ...

Multiple proposals could spell legalisation of hemp and CBD in Israel

Written by CannIntelligence || 4th September 2020 || News analysis |

Israel is considering amending the Dangerous Drugs Ordinance, which – if successful – will have a major impact on the market with hemp and CBD products ...

CBD-Intel regulatory news in brief, 22th August-4th September

Written by CannIntelligence || 4th September 2020 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from Belgium, Germany, Malta, Canada, the US, Brazil, Chile, Colombia, Indonesia, Israel, New Zealand, Pakistan, Paraguay and Peru ...

What impact would the US Drug Enforcement Agency (DEA) rules have on the CBD industry if they were enacted in their current form?

Written by CannIntelligence || 4th September 2020 || Blogs |

First it's important to note that the DEA proposals are only in a draft form and are open to comment until 20th October. They have already received a large number of comments, the majority of which appear to...

Licensing difficulties hold back hemp producers in China’s Yunnan province

Written by CannIntelligence || 3rd September 2020 || News analysis |

Companies seeking licences to produce hemp in the Chinese province of Yunnan face a tightening of the application process, according to some who have successfully negotiated the concealed hurdles ...

UK CBD oil price change index

Written by CannIntelligence || 3rd September 2020 || News analysis |

The average price changes for standard and specialist CBD oils in the...

Podcast: what can European markets do with CBD Novel Food applications?

Written by CannIntelligence || 2nd September 2020 || Podcasts , Resources |

CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European...

Netherlands CBD price reductions

Written by CannIntelligence || 31st August 2020 || Podcasts , Resources |

The percentage of price reductions for brands and products within prominent CBD categories in the...

CBD-Intel regulatory news in brief, 22nd-28th August

Written by CannIntelligence || 28th August 2020 || Alerts Array , Regulatory alerts roundup |

This week's regulatory news in brief includes updates from the Czech Republic, Sweden, Mexico, the US, Ecuador and Israel ...

How significant is Charlotte’s Web being denied a trademark?

Written by CannIntelligence || 27th August 2020 || Blogs |

The immediate impact of the decision is a reduction in certainty for CBD firms - not something they need at a time of significantly heightened uncertainty in other...

LATEST ALERTS

Written by CannIntelligence || 23rd October 2020 || News analysis |

Written by CannIntelligence || 23rd October 2020 || News analysis |

Written by CannIntelligence || 23rd October 2020 || News analysis |

Written by CannIntelligence || 23rd October 2020 || News analysis |

Written by CannIntelligence || 23rd October 2020 || Blogs |

Written by CannIntelligence || 23rd October 2020 || News analysis |

Written by CannIntelligence || 22nd October 2020 || News analysis |

Written by CannIntelligence || 22nd October 2020 || Podcasts , Resources |

Written by CannIntelligence || 19th October 2020 || News analysis |

Written by CannIntelligence || 19th October 2020 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 16th October 2020 || Blogs |

Written by CannIntelligence || 16th October 2020 || News analysis |

Written by CannIntelligence || 15th October 2020 || Regulatory reports |

Written by CannIntelligence || 13th October 2020 || News analysis |

Written by CannIntelligence || 9th October 2020 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 9th October 2020 || News analysis |

Written by CannIntelligence || 9th October 2020 || Blogs |

Written by CannIntelligence || 8th October 2020 || News analysis |

Written by CannIntelligence || 7th October 2020 || News analysis |

Written by CannIntelligence || 5th October 2020 || News analysis |

Written by CannIntelligence || 2nd October 2020 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 2nd October 2020 || News analysis |

Written by CannIntelligence || 2nd October 2020 || Blogs |

Written by CannIntelligence || 1st October 2020 || News analysis |

Written by CannIntelligence || 1st October 2020 || Presentations , Resources |

Written by CannIntelligence || 29th September 2020 || News analysis |

Written by CannIntelligence || 28th September 2020 || News analysis |

Written by CannIntelligence || 25th September 2020 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 25th September 2020 || Blogs |

Written by CannIntelligence || 23rd September 2020 || News analysis |

Written by CannIntelligence || 21st September 2020 || Blogs |

Written by CannIntelligence || 18th September 2020 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 18th September 2020 || News analysis |

Written by CannIntelligence || 17th September 2020 || Regulatory reports |

Written by CannIntelligence || 16th September 2020 || News analysis |

Written by CannIntelligence || 15th September 2020 || News analysis |

Written by CannIntelligence || 14th September 2020 || News analysis |

Written by CannIntelligence || 11th September 2020 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 11th September 2020 || News analysis |

Written by CannIntelligence || 8th September 2020 || News analysis |

Written by CannIntelligence || 7th September 2020 || News analysis |

Written by CannIntelligence || 4th September 2020 || News analysis |

Written by CannIntelligence || 4th September 2020 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 4th September 2020 || Blogs |

Written by CannIntelligence || 3rd September 2020 || News analysis |

Written by CannIntelligence || 3rd September 2020 || News analysis |

Written by CannIntelligence || 2nd September 2020 || Podcasts , Resources |

Written by CannIntelligence || 31st August 2020 || Podcasts , Resources |

Written by CannIntelligence || 28th August 2020 || Alerts Array , Regulatory alerts roundup |

Written by CannIntelligence || 27th August 2020 || Blogs |

Sign up to our newsletter

Start your FREE trial